Home › Therapeutic areas › Infectious Disease › RSV
RSV (2 companies)
Companies with an active program in RSV.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals | DermatologyImmunology+1 | 2 | Approved | $320M | 7 |
| IVVD | Invivyd | Infectious Disease | 1 | Approved | $166M | 5 |
No companies match.